(1)
The Nuclear β-Catenin Expression As a Prognostic Indicator and Its Clinicopathologic Correlates in Endometrial Adenocarcinoma: A Retrospective Study from Albayda Medical Center, Libya. Razi Med J 2026, 363-368. https://doi.org/10.69667/rmj.26229.